TY - JOUR T1 - Alarming downtrend in mechanical thrombectomy rates in African American patients during the COVID-19 pandemic-Insights from STAR JF - Journal of NeuroInterventional Surgery JO - J NeuroIntervent Surg SP - 304 LP - 307 DO - 10.1136/neurintsurg-2020-016946 VL - 13 IS - 4 AU - Sami Al Kasab AU - Eyad Almallouhi AU - Ali Alawieh AU - Pascal Jabbour AU - Ahmad Sweid AU - Robert M Starke AU - Vasu Saini AU - Stacey Q Wolfe AU - Kyle M Fargen AU - Adam S Arthur AU - Nitin Goyal AU - Abhi Pandhi AU - Ilko Maier AU - Jonathan A Grossberg AU - Brian M Howard AU - Stavropoula I Tjoumakaris AU - Ansaar Rai AU - Min S Park AU - Justin R Mascitelli AU - Marios N Psychogios AU - Alejandro M Spiotta Y1 - 2021/04/01 UR - http://jnis.bmj.com/content/13/4/304.abstract N2 - Background The coronavirus disease (COVID-19) pandemic has affected stroke care globally. In this study, we aim to evaluate the impact of the current pandemic on racial disparities among stroke patients receiving mechanical thrombectomy (MT).Methods We used the prospectively collected data in the Stroke Thrombectomy and Aneurysm Registry from 12 thrombectomy-capable stroke centers in the US and Europe. We included acute stroke patients who underwent MT between January 2017 and May 2020. We compared baseline features, vascular risk factors, location of occlusion, procedural metrics, complications, and discharge outcomes between patients presenting before (before February 2020) and those who presented during the pandemic (February to May 2020).Results We identified 2083 stroke patients: of those 235 (11.3%) underwent MT during the COVID-19 pandemic. Compared with pre-pandemic, stroke patients who received MT during the pandemic had longer procedure duration (44 vs 38 min, P=0.006), longer length of hospitalization (6 vs 4 days, P<0.001), and higher in-hospital mortality (18.7% vs 11%, P<0.001). Importantly, there was a lower number of African American patients undergoing MT during the COVID-19 pandemic (609 (32.9%) vs 56 (23.8%); P=0.004).Conclusion The COVID-19 pandemic has affected the care process for stroke patients receiving MT globally. There is a significant decline in the number of African American patients receiving MT, which mandates further investigation. ER -